WI
BIO icon

Wahed Invest’s Bio-Rad Laboratories Class A BIO Stock Holding History

Wahed Invest’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-421
Closed -$115K – 222
2024
Q2 		$115K Buy
421
+22
+6% +$6.4K 0.02% 225
2024
Q1 		$138K Buy
399
+49
+14% +$16.1K 0.03% 219
2023
Q4 		$113K Buy
+350
New +$110K 0.03% 220
2023
Q3 		– Sell
-302
Closed -$114K – 239
2023
Q2 		$114K Buy
302
+25
+9% +$10.2K 0.04% 213
2023
Q1 		$133K Hold
277
– – 0.06% 204
2022
Q4 		$116K Buy
277
+29
+12% +$11.7K 0.06% 202
2022
Q3 		$103K Buy
248
+21
+9% +$10.5K 0.06% 199
2022
Q2 		$112K Buy
+227
New +$118K 0.07% 195
2022
Q1 		– Sell
-252
Closed -$190K – 175
2021
Q4 		$190K Buy
+252
New +$189K 0.11% 165

Other funds holding BIO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return
VAM
Veritas Asset Management London, United Kingdom $5.56B AUM 3.46% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Wahed Invest's BIO Position: Q3 2024 in Review

Wahed Invest sold out of Bio-Rad Laboratories Class A (BIO) in Q3 2024, closing a stake of 421 shares — an estimated $115K sold.

Wahed Invest first reported a position in BIO in Q4 2021 and held it in 9 quarters. The position peaked at $190K in Q4 2021. 438 funds tracked by Wall St. Rank hold BIO as of Q3 2024.

  • Wahed Invest reported no remaining Bio-Rad Laboratories Class A position as of Q3 2024 after selling out during the quarter.
  • Wahed Invest sold 421 Bio-Rad Laboratories Class A shares in Q3 2024, an estimated $115K.
  • Wahed Invest first reported a position in Bio-Rad Laboratories Class A in Q4 2021 and held it in 9 quarters.
  • Wahed Invest's Bio-Rad Laboratories Class A position peaked at $190K in Q4 2021.
  • 438 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q3 2024.

Based on Wahed Invest's 13F filing for Q3 2024, filed 14 Nov 2024.